Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration
Nikos Pantazis(National and Kapodistrian University of Athens), Dominique Costagliola(Inserm), Shema Tariq(University College London), Inmaculada Jarrín(Instituto de Salud Carlos III), Alain Volny Anne(Treatment Action Group), Kholoud Porter(The Royal Free Hospital), Elisa Ruiz-Burga(University College London), Sophie Grabar(Délégation Paris 5), M. John Gill(University of Calgary), Bruno Spire(Inserm), Giota Touloumi(National and Kapodistrian University of Athens), Christina Carlander(Karolinska University Hospital), Caroline Sabin(Primary Health Care), Laurence Meyer(Université Paris-Sud), Marc van der Valk(Academic Medical Center), Fiona Burns(University College London), Ard van Sighem(Stichting HIV Monitoring)
Cited by 24
Related Papers
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987